NCT02601651View on ClinicalTrials.gov

Effect of Perioperative Intravenous Lidocaine on Opioid Consumption and Pain After Laparoscopic Totally Extraperitoneal Inguinal Hernioplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Pain, Postoperative
Interventions
DRUG

Lidocaine

Lignocaine group will receive an intravenous (IV) bolus 1.5 mg/kg at induction followed by continuous infusion of 2 mg/kg/hr until the tracheal extubation.

DRUG

Normal saline

Normal saline group will receive an intravenous normal saline bolus at induction followed by continuous infusion of normal saline until the tracheal extubation

Trial Locations (1)

56700

BP Koirala institute of health sciences, Dharān

All Listed Sponsors
lead

B.P. Koirala Institute of Health Sciences

OTHER

NCT02601651 - Effect of Perioperative Intravenous Lidocaine on Opioid Consumption and Pain After Laparoscopic Totally Extraperitoneal Inguinal Hernioplasty | Biotech Hunter | Biotech Hunter